Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.
2.

Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.

Vanzyl EJ, Rick KRC, Blackmore AB, MacFarlane EM, McKay BC.

PLoS One. 2018 Jan 16;13(1):e0191178. doi: 10.1371/journal.pone.0191178. eCollection 2018.

3.

Rapid Decrease in KRT14 and TP53 mRNA Expression in the Buccal Mucosa of Patients Receiving Total-Body Irradiation for Allogeneic Stem Cell Transplantation.

Chmara J, Browning JWL, Atkins H, Sabloff M, McKay BC.

Radiat Res. 2018 Feb;189(2):213-218. doi: 10.1667/RR14897.1. Epub 2017 Dec 12.

PMID:
29232178
4.

In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.

Hassan EM, Willmore WG, McKay BC, DeRosa MC.

Sci Rep. 2017 Nov 3;7(1):14487. doi: 10.1038/s41598-017-13751-z.

5.

The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses.

Cabrita MA, Bose R, Vanzyl EJ, Pastic A, Marcellus KA, Pan E, Hamill JD, McKay BC.

Gene. 2017 Apr 15;608:86-94. doi: 10.1016/j.gene.2017.01.018. Epub 2017 Jan 21.

PMID:
28119089
6.

A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.

Cabrita MA, Vanzyl EJ, Hamill JD, Pan E, Marcellus KA, Tolls VJ, Alonzi RC, Pastic A, Rambo TM, Sayed H, McKay BC.

PLoS One. 2016 Feb 3;11(2):e0148529. doi: 10.1371/journal.pone.0148529. eCollection 2016.

7.

Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.

Ruddy SC, Lau R, Cabrita MA, McGregor C, McKay BC, Murphy LC, Wright JS, Durst T, Pratt MA.

Mol Cancer Ther. 2014 Jul;13(7):1882-93. doi: 10.1158/1535-7163.MCT-13-1066. Epub 2014 Apr 30.

8.

Post-transcriptional regulation of DNA damage-responsive gene expression.

McKay BC.

Antioxid Redox Signal. 2014 Feb 1;20(4):640-54. doi: 10.1089/ars.2013.5523. Epub 2013 Sep 12. Review.

9.

A novel cis-acting element from the 3'UTR of DNA damage-binding protein 2 mRNA links transcriptional and post-transcriptional regulation of gene expression.

Melanson BD, Cabrita MA, Bose R, Hamill JD, Pan E, Brochu C, Marcellus KA, Zhao TT, Holcik M, McKay BC.

Nucleic Acids Res. 2013 Jun;41(11):5692-703. doi: 10.1093/nar/gkt279. Epub 2013 Apr 19.

10.

Arresting transcription and sentencing the cell: the consequences of blocked transcription.

McKay BC, Cabrita MA.

Mech Ageing Dev. 2013 May-Jun;134(5-6):243-52. doi: 10.1016/j.mad.2013.03.003. Epub 2013 Mar 28. Review.

PMID:
23542592
11.

NF-κB-dependent role for cold-inducible RNA binding protein in regulating interleukin 1β.

Brochu C, Cabrita MA, Melanson BD, Hamill JD, Lau R, Pratt MA, McKay BC.

PLoS One. 2013;8(2):e57426. doi: 10.1371/journal.pone.0057426. Epub 2013 Feb 21.

12.

Compromised genomic integrity impedes muscle growth after Atrx inactivation.

Huh MS, Price O'Dea T, Ouazia D, McKay BC, Parise G, Parks RJ, Rudnicki MA, Picketts DJ.

J Clin Invest. 2012 Dec;122(12):4412-23. doi: 10.1172/JCI63765. Epub 2012 Nov 1.

13.

Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.

Williamson CT, Kubota E, Hamill JD, Klimowicz A, Ye R, Muzik H, Dean M, Tu L, Gilley D, Magliocco AM, McKay BC, Bebb DG, Lees-Miller SP.

EMBO Mol Med. 2012 Jun;4(6):515-27. doi: 10.1002/emmm.201200229. Epub 2012 Mar 13.

14.

Focal adhesion kinase inhibitors are potent anti-angiogenic agents.

Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL.

Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct 20.

15.

The role of mRNA decay in p53-induced gene expression.

Melanson BD, Bose R, Hamill JD, Marcellus KA, Pan EF, McKay BC.

RNA. 2011 Dec;17(12):2222-34. doi: 10.1261/rna.030122.111. Epub 2011 Oct 21.

16.

RNA interference against transcription elongation factor SII does not support its role in transcription-coupled nucleotide excision repair.

Mackinnon-Roy C, Stubbert LJ, McKay BC.

Mutat Res. 2011 Jan 10;706(1-2):53-8. doi: 10.1016/j.mrfmmm.2010.10.010. Epub 2010 Nov 9.

PMID:
21070792
17.
18.

Ultraviolet light induces the sustained unscheduled expression of cyclin E in the absence of functional p53.

Stubbert LJ, Spronck JC, Hamill JD, McKay BC.

Cell Cycle. 2009 Sep 15;8(18):2995-3002. Epub 2009 Sep 25.

PMID:
19713765
19.

The anti-apoptotic role for p53 following exposure to ultraviolet light does not involve DDB2.

Stubbert LJ, Smith JM, Hamill JD, Arcand TL, McKay BC.

Mutat Res. 2009 Apr 26;663(1-2):69-76. doi: 10.1016/j.mrfmmm.2009.01.010. Epub 2009 Feb 5.

PMID:
19428372
20.
21.

DDB2-independent role for p53 in the recovery from ultraviolet light-induced replication arrest.

Stubbert LJ, Hamill JD, Spronck JC, Smith JM, Becerril C, McKay BC.

Cell Cycle. 2007 Jul 15;6(14):1730-40. Epub 2007 May 10.

PMID:
17630510
22.

Regulation of ultraviolet light-induced gene expression by gene size.

McKay BC, Stubbert LJ, Fowler CC, Smith JM, Cardamore RA, Spronck JC.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6582-6. Epub 2004 Apr 15.

23.

Ultraviolet light-induced apoptosis is associated with S-phase in primary human fibroblasts.

McKay BC, Becerril C, Spronck JC, Ljungman M.

DNA Repair (Amst). 2002 Oct 1;1(10):811-20.

PMID:
12531028
24.
25.

Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells.

Billecke CA, Ljungman ME, McKay BC, Rehemtulla A, Taneja N, Ethier SP.

Oncogene. 2002 Jul 4;21(29):4481-9.

26.
27.

UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1.

McKay BC, Chen F, Clarke ST, Wiggin HE, Harley LM, Ljungman M.

Mutat Res. 2001 Mar 7;485(2):93-105.

PMID:
11182541
29.

The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis.

McKay BC, Chen F, Perumalswami CR, Zhang F, Ljungman M.

Mol Biol Cell. 2000 Aug;11(8):2543-51.

30.

Potential roles for p53 in nucleotide excision repair.

McKay BC, Ljungman M, Rainbow AJ.

Carcinogenesis. 1999 Aug;20(8):1389-96.

PMID:
10426782
31.

Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest.

Chang D, Chen F, Zhang F, McKay BC, Ljungman M.

Cell Growth Differ. 1999 Mar;10(3):155-62.

32.

Inhibition of RNA polymerase II as a trigger for the p53 response.

Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay BC.

Oncogene. 1999 Jan 21;18(3):583-92.

35.

Wildtype p53 is required for heat shock and ultraviolet light enhanced repair of a UV-damaged reporter gene.

McKay BC, Francis MA, Rainbow AJ.

Carcinogenesis. 1997 Feb;18(2):245-9.

PMID:
9054614

Supplemental Content

Loading ...
Support Center